BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2878667)

  • 1. Effect of five structurally diverse H2-receptor antagonists on drug metabolism.
    Pasanen M; Arvela P; Pelkonen O; Sotaniemi E; Klotz U
    Biochem Pharmacol; 1986 Dec; 35(24):4457-61. PubMed ID: 2878667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of nizatidine on drug metabolism.
    Klotz U
    Scand J Gastroenterol Suppl; 1987; 136():18-23. PubMed ID: 2892251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of microsomal enzyme activity of the liver by various H2 receptor antagonists].
    Jensen JC; Gugler R
    Z Gastroenterol; 1987 Feb; 25(2):112-8. PubMed ID: 2882636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cimetidine, ranitidine and famotidine on rat hepatic microsomal cytochrome P-450 activities.
    Bast A; Smid K; Timmerman H
    Agents Actions; 1989 Apr; 27(1-2):188-91. PubMed ID: 2568738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of human liver phenacetin O-deethylation by histamine and four histamine H2-receptor antagonists.
    Reilly PE; Mason SR; Gillam EM
    Xenobiotica; 1988 Apr; 18(4):381-7. PubMed ID: 2899931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of famotidine with rat liver microsomes, a study showing less inhibition of drug metabolism than with cimetidine.
    Imai Y; Inada M; Tamura S; Noda S; Kawata S; Minami Y; Tarui S
    Pharmacol Res Commun; 1986 Jul; 18(7):629-38. PubMed ID: 2876442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of H2-receptor antagonists on cytochrome P450 in male ICR mice.
    Kim DH; Kim EJ; Han SS; Roh JK; Jeong TC; Park JH
    Hum Exp Toxicol; 1995 Aug; 14(8):623-9. PubMed ID: 7576828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of human hepatic microsomes and their inhibition by cimetidine and ranitidine.
    Hoensch HP; Hutzel H; Kirch W; Ohnhaus EE
    Eur J Clin Pharmacol; 1985; 29(2):199-206. PubMed ID: 3935464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of H2-receptor- and proton pump inhibitors on some functions of the oxydative and conjugative drug metabolism.
    Scheuch E; Walter R; Hadasová E; Amon I; Siegmund W
    Pharmazie; 1996 Jul; 51(7):493-7. PubMed ID: 8774841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of H2 receptor antagonists on hepatic microsomal drug metabolism and fine morphology of rat liver.
    Mosca P; Freddara U; Lorenzini I; Venturini C; Jezequel AM; Orlandi F
    Pharmacol Res Commun; 1985 Jun; 17(6):513-24. PubMed ID: 2862646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes.
    Orishiki M; Matsuo Y; Nishioka M; Ichikawa Y
    Int J Biochem; 1994 Jun; 26(6):751-8. PubMed ID: 8063004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
    Carrasco M; Gaule C; Vega P; del Villar E
    Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-directed phenotyping of cytochrome P-450-dependent aryl hydrocarbon hydroxylase and 7-ethoxycoumarin deethylase in mammalian tissues.
    Fujino T; West D; Park SS; Gelboin HV
    J Biol Chem; 1984 Jul; 259(14):9044-50. PubMed ID: 6204978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the histamine H2-receptor antagonist etintidine with rat liver cytochrome P-450: a comparison with cimetidine.
    Schulz M; Schmoldt A
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):453-8. PubMed ID: 2893298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine: a notable lack of drug interactions.
    Humphries TJ
    Scand J Gastroenterol Suppl; 1987; 134():55-60. PubMed ID: 2889260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2013 Oct; 37(8):476-85. PubMed ID: 23857299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
    Bast A; Savenije-Chapel EM; Kroes BH
    Xenobiotica; 1984 May; 14(5):399-408. PubMed ID: 6089451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].
    Klotz U; Reimann I
    Klin Wochenschr; 1983 Jul; 61(13):625-32. PubMed ID: 6136626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.